2 Clinical Trials for Various Conditions
To measure the efficacy and safety outcomes of SLT performed by optometrists.
Qlaris' Phase 2 clinical trial investigating the safety, tolerability, and ocular hypotensive efficacy of QLS-111 in primary open-angle glaucoma (POAG) or ocular hypertension patients.